Академический Документы
Профессиональный Документы
Культура Документы
A ge
Vaccine
Route
Type
1 day 14 -21 days 14-21 days 5 wk 8-10 wk 10-12 wk 10-12 wk 10-12 wk 10-14 wk or 18 wk 12-14 wk 16-18 wk and every
SC Water
Newcastle/infectious bronchitis Water or coarse spray B1/Mass Newcastle/infectious bronchitis Water or coarse spray B1 or LaSota/Mass Encephalomyelitis Fowlpox Laryngotracheitis Mycoplasma gallisepticum M gallisepticum
Live, chick-embryo origin Modified live Modified live Mild live strain Inactivated B1 or LaSota/Mass B1 or LaSota/Mass Inactivated
* This
is an e x am ple of a vaccination program . Individual program s are highly variable and re fle ct local conditions, dise ase pre vale nce , se ve rity of challe nge , and individual pre fe re nce s.
The
use of M gallisepticum vaccine is re gulate d or prohibite d in som e state s. SB-1 or MDV301 m ay be com bine d with turk e y he rpe svirus in som e are as. Vaccination for infe ctious bursal dise ase , laryngotrache itis, and fowlpox de pe nds on local re quire m e nts. O the r strains of infe ctious bronchitis (C onne cticut, Ark ansas 99, Florida 88, e tc) are include d in som e are as. M gallisepticum and Haemophilus gallinarum (coryza) are use d only on infe cte d, m ultiage pre m ise s in som e are as.
2011; Me rck Sharp & Dohm e C orp., a subsidiary of Me rck & C o., Inc.W hite house Station, NJ USA. All R ights R e se rve d.
Disclaim e r / Fe e dback